Scott Thomas Jackson Glycomimetics Inc (GLYC) insider trading activity

Scott Thomas Jackson is of GLYCOMIMETICS INC. Currently has a direct ownership of 5,250 shares of GLYC, which is worth approximately $2,257. The most recent transaction as insider was on May 18, 2021, when has been sold 5,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.25K

0% 3M change

0% 12M change

Total Value Held $2,257

Scott Thomas Jackson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 18 2021	BUY Grant, award, or other acquisition	-	5,250 Added 50.0%	5,250 Common Stock

Also insider at

SPRO

Spero Therapeutics, Inc. Healthcare

MGNX

MACROGENICS INC Healthcare

Director

MURA

Mural Oncology plc

STJ